뒤로
Hua Medicine(02552.HK) 가격
02552.HK 주가 차트
HUA MEDICINE-B (02552.HK)
Hua Medicine
HK$3.12
0.64%
$0.02
장 종료: Feb 16, 12:00:00 HKT
주요 통계
이전 종가
$3.04
시가
$3.1
일일 범위
$2.99 - $3.12
52주 범위
$1.24 - $4.95
거래량
--
평균 거래량
3.5M
EPS(TTM)
1.21
배당수익률
--
시가총액
$3.0B
HUA MEDICINE-B란 무엇인가요?
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
